Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam Lenhard

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
BMC Cancer|January 5, 2012
Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancerMiriam Lenhard, Alexandra Tsvilina, Lan Schumacher, et al.
BMC Cancer|November 27, 2012
Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survivalMiriam Lenhard, Lennerová Tereza, Sabine Heublein, et al.
Histology and Histopathology|January 1, 2013
Thyroid hormone receptor (TR)alpha and TRbeta expression in breast cancerNina Ditsch, Bettina Toth, Isabelle Himsl, et al.
Journal of Reproductive Immunology|February 26, 2013
Inducers of G-protein coupled estrogen receptor (GPER) in endometriosis: potential implications for macrophages and follicle maturationSabine Heublein, Thomas Vrekoussis, Christina Kuhn, et al.
Anticancer Research|July 2, 2010
Thyroid function in breast cancer patientsNina Ditsch, Susanne Liebhardt, Franz Von Koch, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 2, 2009
Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancerHans Dieplinger, Donna Pauler Ankerst, Alexander Burges, et al.
BMC Cancer|October 22, 2013
KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implantsSabine Heublein, Katinka Grasse, Harald Hessel, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 4, 2014
Malnutrition and clinical outcome in gynecologic patientsLinda Hertlein, Angela Kirschenhofer, Sophie Fürst, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|May 11, 2012
The G-protein-coupled estrogen receptor (GPER) is expressed in normal human ovaries and is upregulated in ovarian endometriosis and pelvic inflammatory disease involving the ovarySabine Heublein, Miriam Lenhard, Thomas Vrekoussis, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|November 24, 2011
The association between vitamin D receptor expression and prolonged overall survival in breast cancerNina Ditsch, Bettina Toth, Doris Mayr, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
BMC Cancer|January 5, 2012
Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancerMiriam Lenhard, Alexandra Tsvilina, Lan Schumacher, et al.
BMC Cancer|November 27, 2012
Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survivalMiriam Lenhard, Lennerová Tereza, Sabine Heublein, et al.
Histology and Histopathology|January 1, 2013
Thyroid hormone receptor (TR)alpha and TRbeta expression in breast cancerNina Ditsch, Bettina Toth, Isabelle Himsl, et al.
Journal of Reproductive Immunology|February 26, 2013
Inducers of G-protein coupled estrogen receptor (GPER) in endometriosis: potential implications for macrophages and follicle maturationSabine Heublein, Thomas Vrekoussis, Christina Kuhn, et al.
Anticancer Research|July 2, 2010
Thyroid function in breast cancer patientsNina Ditsch, Susanne Liebhardt, Franz Von Koch, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 2, 2009
Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancerHans Dieplinger, Donna Pauler Ankerst, Alexander Burges, et al.
BMC Cancer|October 22, 2013
KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implantsSabine Heublein, Katinka Grasse, Harald Hessel, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 4, 2014
Malnutrition and clinical outcome in gynecologic patientsLinda Hertlein, Angela Kirschenhofer, Sophie Fürst, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|May 11, 2012
The G-protein-coupled estrogen receptor (GPER) is expressed in normal human ovaries and is upregulated in ovarian endometriosis and pelvic inflammatory disease involving the ovarySabine Heublein, Miriam Lenhard, Thomas Vrekoussis, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|November 24, 2011
The association between vitamin D receptor expression and prolonged overall survival in breast cancerNina Ditsch, Bettina Toth, Doris Mayr, et al.
Pageof 4